TCIM
SPPI

TIAA CREF Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

TIAA CREF Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.08M Sell
194,982
-154,914
-44% -$1.66M ﹤0.01% 1979
2018
Q4 		$3.06M Sell
349,896
-57,622
-14% -$734K ﹤0.01% 1688
2018
Q3 		$6.85M Buy
407,518
+148,564
+57% +$3.22M ﹤0.01% 1363
2018
Q2 		$5.43M Buy
258,954
+43,601
+20% +$808K ﹤0.01% 1541
2018
Q1 		$3.46M Sell
215,353
-192,931
-47% -$3.82M ﹤0.01% 1793
2017
Q4 		$7.74M Buy
408,284
+187,453
+85% +$3.4M 0.01% 1309
2017
Q3 		$3.11M Buy
220,831
+8,477
+4% +$76.7K ﹤0.01% 1908
2017
Q2 		$1.58M Sell
212,354
-41,913
-16% -$274K ﹤0.01% 2319
2017
Q1 		$1.65M Buy
254,267
+45,108
+22% +$252K ﹤0.01% 2249
2016
Q4 		$927K Sell
209,159
-172,598
-45% -$724K ﹤0.01% 2575
2016
Q3 		$1.78K Sell
381,757
-81,808
-18% -$485K ﹤0.01% 2237
2016
Q2 		$3.05M Buy
463,565
+105,308
+29% +$744K ﹤0.01% 1866
2016
Q1 		$2.28M Buy
358,257
+140,490
+65% +$721K ﹤0.01% 1998
2015
Q4 		$1.31M Sell
217,767
-10,457
-5% -$59.8K ﹤0.01% 2411
2015
Q3 		$1.36M Sell
228,224
-6,994
-3% -$48.6K ﹤0.01% 2377
2015
Q2 		$1.61M Sell
235,218
-30,352
-11% -$193K ﹤0.01% 2434
2015
Q1 		$1.61M Sell
265,570
-6,294
-2% -$41.9K ﹤0.01% 2357
2014
Q4 		$1.88M Sell
271,864
-8,457
-3% -$62.2K ﹤0.01% 2286
2014
Q3 		$2.28M Sell
280,321
-10,466
-4% -$81.9K ﹤0.01% 2138
2014
Q2 		$2.36M Buy
290,787
+3,949
+1% +$30K ﹤0.01% 2205
2014
Q1 		$2.25M Sell
286,838
-4,210
-1% -$35.6K ﹤0.01% 2170
2013
Q4 		$2.58M Sell
291,048
-7,339
-2% -$65.5K ﹤0.01% 2099
2013
Q3 		$2.5M Sell
298,387
-10,880
-4% -$88.1K ﹤0.01% 2068
2013
Q2 		$2.31M Buy
+309,267
New +$2.37M ﹤0.01% 2075

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TIAA CREF Investment Management's SPPI Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 44% in Q1 2019, selling an estimated $1.66M and leaving 194,982 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

TIAA CREF Investment Management first reported a position in SPPI in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.74M in Q4 2017. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

  • TIAA CREF Investment Management held 194,982 shares of Spectrum Pharmaceuticals Inc worth $2.08M as of Q1 2019.
  • TIAA CREF Investment Management sold 154,914 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $1.66M.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1979 holding.
  • TIAA CREF Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Spectrum Pharmaceuticals Inc position peaked at $7.74M in Q4 2017.
  • 173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.